Skip to NavigationSkip to content

Pharmafile - Research and Development News

Following the surprise resignation of current FDA Commissioner Dr Scott Gottlieb a week earlier, Dr Norman ‘Ned’ Sharpless, Director of the...
Janssen’s ulcerative colitis treatment, Stelara (ustekinumab subcutaneous) has shown positive results as maintenance therapy in phase 3 trials.
Eli Lilly’s Cyramza has succeeded in hitting its primary endpoint at Phase 3 in combination with erlotinib, the company said, as a first-line...
The healthcare industry could take up to five years to stabilise in the event of a no-deal Brexit, according to pharmaceutical industry...
The FDA has approved a new generic version of blood pressure drug valsartan. The approval comes amid shortages in supply after recalls were made in...
- FDA Commissioner Scott Gottlieb announces resignation - London man becomes second in world to be cured of HIV - Indian government set to colour...
Gilead has lifted the curtain on new Phase 2/3 efficacy data for Biktarvy, revealing that the drug demonstrated high efficacy in maintaining...
A small biotech based in Clackmannanshire, Scotland expects to turnover an additional £20 million from sales of its HIV diagnostics kit after the...
Allergan has released new, but unfortunately disappointing Phase 3 data for its own therapy rapastinel, confirming that it failed to outperform...
Dr Scott Gottlieb, the 23rd Commissioner of the US Food and Drug Administration (FDA), stoked surprise throughout the industry with the...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches